The History of Medicine a Beginner’S Guide
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Diagnosis, Treatment, and Prognosis of Glioma Five New Things
Diagnosis, treatment, and prognosis of glioma Five new things s the profession of neurology becomes in- creasingly subspecialized, it becomes more A and more difficult for general neurologists to feel comfortable with every category of disease. At no time is this felt more keenly than when an imaging procedure has been performed on a pa- tient for a seizure, headache, or focal neurologic complaint and a brain tumor is discovered. In con- trast to consulting with a patient with a movement disorder or neuromuscular disease, there is no time to craft the discussion and discuss a differential diag- nosis. As with demyelinating disease or stroke, the scan result dictates an immediate conversation with the patient, but in contrast to those disorders this takes place from the perspective of a provider who understands that the eventual outcome for the pa- tient is likely to be guarded. How to give that message with tact, candor, and some optimism could be the sole topic of this article but, instead, we focus on 5 new ideas that are changing the management of brain tumor patients in the hopes that these points might prove useful during those times. Lynne P. Taylor, MD PROGNOSIS AND GLIOMA SUBTYPES In his pioneering work “Death Foretold,” Dr. Nicholas Chris- takis1 says “prognosis gives diagnosis its affective component, striking fear in patients and physicians Address correspondence and alike.” There has traditionally been a lot of therapeutic nihilism about the treatment of glioblastoma, but reprint requests to Dr. Lynne P. that is now changing. Previously believed to be one homogeneous group of tumors based on clinicopath- Taylor, X7NEU, Virginia Mason Medical Center, 1100 9th ologic and histologic assessments, we are now finding that subgroups exist within these tumors that one Avenue, Seattle, WA 98101 day may allow us to better predict which chemotherapy option is best for each individual patient. -
Artificial Intelligence in Health Care: the Hope, the Hype, the Promise, the Peril
Artificial Intelligence in Health Care: The Hope, the Hype, the Promise, the Peril Michael Matheny, Sonoo Thadaney Israni, Mahnoor Ahmed, and Danielle Whicher, Editors WASHINGTON, DC NAM.EDU PREPUBLICATION COPY - Uncorrected Proofs NATIONAL ACADEMY OF MEDICINE • 500 Fifth Street, NW • WASHINGTON, DC 20001 NOTICE: This publication has undergone peer review according to procedures established by the National Academy of Medicine (NAM). Publication by the NAM worthy of public attention, but does not constitute endorsement of conclusions and recommendationssignifies that it is the by productthe NAM. of The a carefully views presented considered in processthis publication and is a contributionare those of individual contributors and do not represent formal consensus positions of the authors’ organizations; the NAM; or the National Academies of Sciences, Engineering, and Medicine. Library of Congress Cataloging-in-Publication Data to Come Copyright 2019 by the National Academy of Sciences. All rights reserved. Printed in the United States of America. Suggested citation: Matheny, M., S. Thadaney Israni, M. Ahmed, and D. Whicher, Editors. 2019. Artificial Intelligence in Health Care: The Hope, the Hype, the Promise, the Peril. NAM Special Publication. Washington, DC: National Academy of Medicine. PREPUBLICATION COPY - Uncorrected Proofs “Knowing is not enough; we must apply. Willing is not enough; we must do.” --GOETHE PREPUBLICATION COPY - Uncorrected Proofs ABOUT THE NATIONAL ACADEMY OF MEDICINE The National Academy of Medicine is one of three Academies constituting the Nation- al Academies of Sciences, Engineering, and Medicine (the National Academies). The Na- tional Academies provide independent, objective analysis and advice to the nation and conduct other activities to solve complex problems and inform public policy decisions. -
Surgery Guidelines Infection Prevention
SURGERY GUIDELINES SURGICAL SITE INFECTION: REDUCING YOUR RISK A surgical site infection is a Stanford Hospital & Clinics is committed to implementing strategies to improve risk with any type of surgery. surgical care and to reduce the risk of You can take steps to reduce surgical site infections. your risk of surgical site We want your surgical experience at Stanford Hospital & Clinics to be positive. infection and complications. That experience includes educational • Talk with your healthcare provider materials that describe the process of your about your risk of infection and review surgery and the measures we take to ensure your safety. It is especially important to steps you can take to reduce your reduce the risk of infection. risk prior to the procedure. These are general guidelines. You will • Know the signs and symptoms be provided with more specific instructions of surgical site infection. related to your surgery before your discharge from the hospital. • Know how to reduce your risk while you are in the hospital. INFECTION PREVENTION stanfordhospital.org stanfordhospital.org PRIOR TO DAY OF AFTER SURGERY SURGERY SURGERY KEY POINTS HEALTHCARE TEAMS’ ROLE IN PREVENTION After your surgery and hospital stay, it is Tell your healthcare provider about other • Your surgeon may use electric clippers to important to watch for any changes in your medical problems you may have. Factors remove some of your hair before surgery. symptoms. Call your physician immediately or such as diabetes, obesity, smoking and some • Your surgical team will apply a skin antiseptic go to the nearest emergency room if you are medications could affect your surgery and immediately before the surgery experiencing any of the following symptoms: your treatment. -
Sports Medicine Examination Outline
Sports Medicine Examination Content I. ROLE OF THE TEAM PHYSICIAN 1% A. Ethics B. Medical-Legal 1. Physician responsibility 2. Physician liability 3. Preparticipation clearance 4. Return to play 5. Waiver of liability C. Administrative Responsibilities II. BASIC SCIENCE OF SPORTS 16% A. Exercise Physiology 1. Training Response/Physical Conditioning a.Aerobic b. Anaerobic c. Resistance d. Flexibility 2. Environmental a. Heat b.Cold c. Altitude d.Recreational diving (scuba) 3. Muscle a. Contraction b. Lactate kinetics c. Delayed onset muscle soreness d. Fiber types 4. Neuroendocrine 5. Respiratory 6. Circulatory 7. Special populations a. Children b. Elderly c. Athletes with chronic disease d. Disabled athletes B. Anatomy 1. Head/Neck a.Bone b. Soft tissue c. Innervation d. Vascular 2. Chest/Abdomen a.Bone b. Soft tissue c. Innervation d. Vascular 3. Back a.Bone b. Soft tissue c. Innervation 1 d. Vascular 4. Shoulder/Upper arm a. Bone b. Soft tissue c. Innervation d. Vascular 5. Elbow/Forearm a. Bone b. Soft tissue c. Innervation d. Vascular 6. Hand/Wrist a. Bone b. Soft tissue c. Innervation d. Vascular 7. Hip/Pelvis/Thigh a. Bone b. Soft tissue c. Innervation d. Vascular 8. Knee a. Bone b. Soft tissue c. Innervation d. Vascular 9. Lower Leg/Foot/Ankle a. Bone b. Soft tissue c. Innervation d. Vascular 10. Immature Skeleton a. Physes b. Apophyses C. Biomechanics 1. Throwing/Overhead activities 2. Swimming 3. Gait/Running 4. Cycling 5. Jumping activities 6. Joint kinematics D. Pharmacology 1. Therapeutic Drugs a. Analgesics b. Antibiotics c. Antidiabetic agents d. Antihypertensives e. -
New Patient Medical History Form
NEW PATIENT MEDICAL HISTORY FORM Full Name: Date: Birth Date: Age: ALLERGIES o NO ALLERGIES ALLERGY ALLERGIC REACTION MEDICATIONS MEDICATIONS DOSE TIMES PER DAY (Please list ALL) (Mg., pill, etc.) If you need more room to list medications, please write them on a blank sheet of paper with the required information HEALTH MAINTENANCE SCREENING TEST HISTORY CHolesterol Date: Facility/Provider: Abnormal Result? Y N Colonoscopy/SIGMOID Date: Facility/Provider: Abnormal Result? Y N Mammogram Date: Facility/Provider: Abnormal Result? Y N PAP SMEAR Date: Facility/Provider: Abnormal Result? Y N BONE density Date: Facility/Provider: Abnormal Result? Y N VACCINATION HISTORY Last Tetanus Booster or TdaP: Last Pnuemovax (Pneumonia): Last Flu Vaccine: Last Prevnar: Last Zoster Vaccine (Shingles): PERSONAL MEDICAL HISTORY DISEASE/CONDITION CURRENT PAST COMMENTS Alcoholism/Drug Abuse Asthma Cancer (type:_________________________________) Depression/Anxiety/Bipolar/Suicidal Diabetes (type:_______________________________) Emphysema (COPD) Heart Disease High Blood Pressure (hypertension) High Cholesterol Hypothyroidism/Thyroid Disease Renal (kidney) Disease Migraine Headaches Stroke Other: Other: SURGERIES TYPE (specify left/right) Date Location/Facility WOMEN’S HEALTH HISTORY Date of Last Menstrual Cycle: Age of First Menstruation: _____ Age of Menopause: _____ Total Number of Pregnancies: Number of Live Births: Pregnancy Complications: Patient Name: DOB: family MEDICAL HISTORY o NO Significant Family History IS KNOWN 4 CHECK ALL THat apply Stroke Cancer -
Pathology and Laboratory Medicine 1
Pathology and Laboratory Medicine 1 and hepatic pathology. The rotation consists of daily interpretation of Pathology and subspecialty biopsies, participation in subspecialty conferences, slide set study, and assigned readings. Students participate in their own Laboratory Medicine learning by setting their rotation objectives with faculty at the start of their elective and following through with a schedule of clinical, laboratory and core lecture conferences. Students will need to obtain the appropriate Pathologists play many roles in medicine, from interpreting surgical staff members' permission for the rotation as follows: dermatopathology biopsies to supervising clinical laboratory testing. It has been estimated (Garth Fraga); neuropathology (Kathy Newell); renal pathology (Timothy that 70% of all medical decisions are based on data generated by Fields); breast pathology (Fang Fan); hepatic pathology (Maura O'Neil). pathology departments. The department of Pathology and Laboratory Prerequisite: Completion of the core clinical clerkships and permission of Medicine at KUMC plays an integral role in the core curriculum and also the faculty. LEC. offers elective courses to medical students interested in learning more about laboratory practice. Students in elective rotations participate in daily teaching conferences and specimen “sign-out” at the University of Kansas Hospital. They receive hands-on exposure to pathology technical methodology in the surgical pathology suite, cytopathology and hematopathology. PAON 920. Molecular Medicine: Approaches & Ethics. 2 Hours. Molecular Medicine: Approaches Ethics is a two semester course for first year MD-PhD students taught by the Director of the MD- PhD Program, with other faculty from the basic science and clinical departments. Through lectures, small group discussion, online modules, evaluation of primary literature, and presentations/discussions with current KUMC faculty, students will be introduced to the process of scientific investigation. -
Medications to Avoid Before Surgery
ENTRUST MEDICAL GROUP Pre‐operative Information Medications to Avoid Before Surgery It is important to avoid certain medications prior to surgery. The following medications can have effects on bleeding, swelling, increase the risk of blood clots, and cause other problems if taken around the time of surgery. Please notify your surgeon’s office if you are taking any vitamins, herbal medications/supplements as these can also cause problems during your surgery and should not be taken for the two week period before surgery and one week after surgery. It is extremely important that if you come down with a cold, fever, rash, or “any new” medical problem close to your surgery date, you should notify your surgeon’s office immediately. Section One: The following drugs contain aspirin and/or aspirin like effects that may affect your surgery (abnormal bleeding and bruising). These drugs should be avoided for at least two weeks prior to surgery. A.P.C. Doloprin Nuprin A.S.A. Easprin Orudis A.S.A. Enseals Ecotrin Pabalate‐SF Advil Emprin with Codeine Pamelor Aleve Endep Parnate Alka‐Seltzer Plus Equagesic Tablets Percodan Alka‐Seltzer Etrafon Pepto‐Bismol (all types) Anacin Excedrin Persantine Anaprox Feldene Phenteramine Ansaid Fiorinal Phenylbutzone Argesic Flagly Ponstel Arthritis pain formula Four Way Cold Tablets Propoxyphene Compound Arthritis strength Bufferin Gemnisyn Robaxisal Arthropan Liquid Gleprin Rufen AS.A. Goody’s S‐A‐C Ascriptin Ibuprofen (all types) Saleto Asperbuf Indocin Salocol Aspergum Indomethacin Sine‐Aid/Sine‐Off/Sinutab Aspirin (all brands) Lanorinal SK‐65 Compound Atromid Lioresal St. Joseph’s Cold Tab B.C. -
Organ Transplant Discrimination Against People with Disabilities Part of the Bioethics and Disability Series
Organ Transplant Discrimination Against People with Disabilities Part of the Bioethics and Disability Series National Council on Disability September 25, 2019 National Council on Disability (NCD) 1331 F Street NW, Suite 850 Washington, DC 20004 Organ Transplant Discrimination Against People with Disabilities: Part of the Bioethics and Disability Series National Council on Disability, September 25, 2019 This report is also available in alternative formats. Please visit the National Council on Disability (NCD) website (www.ncd.gov) or contact NCD to request an alternative format using the following information: [email protected] Email 202-272-2004 Voice 202-272-2022 Fax The views contained in this report do not necessarily represent those of the Administration, as this and all NCD documents are not subject to the A-19 Executive Branch review process. National Council on Disability An independent federal agency making recommendations to the President and Congress to enhance the quality of life for all Americans with disabilities and their families. Letter of Transmittal September 25, 2019 The President The White House Washington, DC 20500 Dear Mr. President, On behalf of the National Council on Disability (NCD), I am pleased to submit Organ Transplants and Discrimination Against People with Disabilities, part of a five-report series on the intersection of disability and bioethics. This report, and the others in the series, focuses on how the historical and continued devaluation of the lives of people with disabilities by the medical community, legislators, researchers, and even health economists, perpetuates unequal access to medical care, including life- saving care. Organ transplants save lives. But for far too long, people with disabilities have been denied organ transplants as a result of unfounded assumptions about their quality of life and misconceptions about their ability to comply with post-operative care. -
Cardiovascular Assessment
Cardiovascular Assessment A Home study Course Offered by Nurses Research Publications P.O. Box 480 Hayward CA 94543-0480 Office: 510-888-9070 Fax: 510-537-3434 No unauthorized duplication photocopying of this course is permitted Editor: Nurses Research 1 HOW TO USE THIS COURSE Thank you for choosing Nurses Research Publication home study for your continuing education. This course may be completed as rapidly as you desire. However there is a one-year maximum time limit. If you have downloaded this course from our website you will need to log back on to pay and complete your test. After you submit your test for grading you will be asked to complete a course evaluation and then your certificate of completion will appear on your screen for you to print and keep for your records. Satisfactory completion of the examination requires a passing score of at least 70%. No part of this course may be copied or circulated under copyright law. Instructions: 1. Read the course objectives. 2. Read and study the course. 3. Log back onto our website to pay and take the test. If you have already paid for the course you will be asked to login using the username and password you selected when you registered for the course. 4. When you are satisfied that the answers are correct click grade test. 5. Complete the evaluation. 6. Print your certificate of completion. If you have a procedural question or “nursing” question regarding the materials, call (510) 888-9070 for assistance. Only instructors or our director may answer a nursing question about the test. -
How Hippocratic Traditions Revolutionized Greek Medicine Presenter: Emily Siniscalco Faculty Sponsor: Robert Sullivan
A Sense of Humor: How Hippocratic Traditions Revolutionized Greek Medicine Presenter: Emily Siniscalco Faculty Sponsor: Robert Sullivan The Hippocratic Corpus is a collection of medical texts written by Hippocrates, an ancient Greek physician, and his students. These texts describe specific medical practices followed by Hippocratic physicians and contain many observations about diseases and their progression in the human body. Ancient Greek medicine did exist before the development of Hippocratic medicine; however, it was much less organized and sophisticated. Here, I aim to identify the ways in which Hippocratic medicine revolutionized medical traditions in ancient Greece. This research is based on analysis of multiple Hippocratic works, including Aphorisms, Epidemics, Affections, and The Hippocratic Oath. These works are all original documents developed during and after the life of Hippocrates in the fourth and fifth centuries BCE. Examination of such texts reveals the influence of Hippocratic tradition on many advancements in Greek medicine, particularly in the way physicians understood and treated diseases as well as the way medicine was practiced as a whole. In particular, Hippocratic tradition contributed to Greek medicine by removing disease from a supernatural context, increasing accurate prognoses based on detailed observations, and promoting personalized medical treatments. These were all significant developments in western medical tradition, as they increased the accuracy of prognoses and effectivity of treatments, ultimately resulting in a higher standard of patient care. This presentation will primarily focus on Hippocratic methods of observation-based prognosis and the effects of such methods on physician-prescribed treatments. Additionally, it will briefly address the ways in which Hippocratic medicine has influenced modern medicinal practices, and the ways in which modern medicine could still learn from the ancient Greek Hippocratic tradition. -
The History of the Relationship Between the Concept and Treatment of People with Down's Syndrome in Britain and America from 1866 to 1967
THE HISTORY OF THE RELATIONSHIP BETWEEN THE CONCEPT AND TREATMENT OF PEOPLE WITH DOWN'S SYNDROME IN BRITAIN AND AMERICA FROM 1866 TO 1967. BY Lilian Serife ZihniB.Sc. P.G.C.E. FOR THE DEGREE OF DOCTOR OF PHILOSOPHY IN THE HISTORY OF MEDICINE UNIVERSITY COLLEGE LONDON 1 Abstract This thesis fills a gap in the history of mental handicap by focusing on a specific mentally handicapping condition, Down's syndrome, in Britain and America. This approach has facilitated an examination of how various scientific and social developments have actually affected a particular group of people with handicaps. The first chapter considers certain historiographical problems this research has raised. The second analyses the question of why Down's syndrome, which has certain easily identifiable characteristics associated with it, was not recognised as a distinct condition until 1866 in Britain. Subsequent chapters focus on the concept and treatment of Down's syndrome by the main nineteenth and twentieth century authorities on the disorder. The third chapter concentrates on John Langdon Down's treatment of 'Mongolian idiots' at the Royal Earlswood Asylum. The fourth chapter examines Sir Arthur Mitchell's study of 'Kalmuc idiots' in private care. The fifth considers how Down's and Mitchell's theories were developed by later investigators, with particular reference to George Shuttleworth's work. Archive materials from the Royal Albert, Royal Earlswood and Royal Scottish National Institutions are used. The sixth focuses on the late nineteenth century American concept and treatment of people with Down's syndrome through an analysis of the work of Albert Wilmarth. -
Early History of Infectious Disease
© Jones and Bartlett Publishers. NOT FOR SALE OR DISTRIBUTION CHAPTER ONE EARLY HISTORY OF INFECTIOUS 1 DISEASE Kenrad E. Nelson, Carolyn F. Williams Epidemics of infectious diseases have been documented throughout history. In ancient Greece and Egypt accounts describe epidemics of smallpox, leprosy, tuberculosis, meningococcal infections, and diphtheria.1 The morbidity and mortality of infectious diseases profoundly shaped politics, commerce, and culture. In epidemics, none were spared. Smallpox likely disfigured and killed Ramses V in 1157 BCE, although his mummy has a significant head wound as well.2 At times political upheavals exasperated the spread of disease. The Spartan wars caused massive dislocation of Greeks into Athens triggering the Athens epidemic of 430–427 BCE that killed up to one half of the population of ancient Athens.3 Thucydides’ vivid descriptions of this epidemic make clear its political and cultural impact, as well as the clinical details of the epidemic.4 Several modern epidemiologists have hypothesized on the causative agent. Langmuir et al.,5 favor a combined influenza and toxin-producing staphylococcus epidemic, while Morrens and Chu suggest Rift Valley Fever.6 A third researcher, Holladay believes the agent no longer exists.7 From the earliest times, man has sought to understand the natural forces and risk factors affecting the patterns of illness and death in society. These theories have evolved as our understanding of the natural world has advanced, sometimes slowly, sometimes, when there are profound break- throughs, with incredible speed. Remarkably, advances in knowledge and changes in theory have not always proceeded in synchrony. Although wrong theories or knowledge have hindered advances in understanding, there are also examples of great creativity when scientists have successfully pursued their theories beyond the knowledge of the time.